Pub. Date : 2003 Oct
PMID : 14551502
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | DPD-inhibiting oral fluoropyrimidines showing promise in early clinical studies included UFT (the 5-FU prodrug, tegafur, plus the DPD substrate, uracil), eniluracil (an irreversible DPD inhibitor that improves the oral bioavailability of 5-FU) and S-1 (tegafur plus a reversible DPD inhibitor, 5-chloro-2,4-dihydroxypyridine, and oxonic acid). | Tegafur | dihydropyrimidine dehydrogenase | Homo sapiens |